Funded by a student scholarship of the German Ophthalmologic Society (LPA).
Disclosure: K. Wall, None; L.P. Arend, None; L. von der Emde, Heidelberg Engineering (R), Böhringer Ingelheim (C); M. Saßmannshausen, Heidelberg Engineering (F); Optos (F), Zeiss (F), CenterVue (F), Nidek (F); F.G. Holz, Acucela (C, F), Allergan (F), Apellis (C, F), Bayer (C, F), Boehringer-Ingelheim (C), Bioeq/Formycon (F, C), CenterVue (F), Ellex (F), Roche/Genentech (C, F), Geuder (C, F), Graybug (C), Gyroscope (C), Heidelberg Engineering (C, F), IvericBio (C, F), Kanghong (C, F), LinBioscience (C), NightStarX (F), Novartis (C, F), Optos (F), Oxurion (C), Pixium Vision (C, F), Oxurion (C), Stealth BioTherapeutics (C), Zeiss (F, C); T. Ach, Bayer (C), Roche (C), Novartis (C), Novartis (R), Heidelberg Engineering (C), Apellis Pharmaceuticals (C), Nidek (C, R)